About this trial
To demonstrate that postoperative pain secondary to Milligan and Morgan hemorrhoidectomy with Caiman® (AESCULAP®) and subsequent oral conventional analgesia is at least not greater than that generated after hemorrhoidectomy with monopolar diathermy and intravenous analgesia with care home at discharge.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All patients with 2 or 3 bundles of grade III-IV hemorrhoids (Goligher classification) clinically symptomatic and subject to outpatient hemorrhoidectomy
Voluntary participation.
ASA I-II-III.
Disqualifiers
Failure to meet the inclusion criteria.
ASA IV.
Allergic to Paracetamol, derivatives of morphine.
Allergic to NSAIDs.
Trial design
Parallel
Treatments tested in this trial
Monopolar Hemorroidecotmy
Procedure/SurgeryHemorrhoidectomy with monopolar diathermy
Caiman Hemorroidectomy
Procedure/SurgeryHemorrhoidectomy with Caiman® bipolar energy
Treatment groups
Trial outcomes
Primary outcomes
Visual analogue scale (VAS)
Postoperative pain: value 0 (no pain) - 10 (maximum pain)
Secondary outcomes
Wound healing time
A healed wound is considered when all post-hemorrhoidectomy wounds of 2-3 bundles are epithelialized
Post-surgery satisfaction survey
Phone checklist survey
Wexner scale
Assessment of fecal incontinence o a scale from 0 (never incontinence) to 4 (always), obtaining a score between 0 and 20.
Number of emergency consultations
revision of Database
Sponsors and contacts
Click on the lead sponsor to view all of their trials.